Ascendis Pharma A/S logo

ASNDAscendis Pharma A/S

ASND Stock Price, Valuation & Chart | Ascendis Pharma A/S

Compare

ASND Historical price chart

ASND Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization16.16B
PE Ratio-107.5
EPS-2.42
Trading Volume559.70K
Today's High/Low266.63/256.27
Dividend Yield0.00
52 Week High/Low282.15/186.05
Shares Outstanding62.11M
ASND Financial Statement
ASND Analyst ratings
ASND Analysis & performance metrics

ASND Company profile

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth…

ASND Management team

Management
Flemming Steen Jensen
Executive Vice President of Product Supply & Quality
Jan Moller MikkelsenCEO
President, Chief Executive Officer, Member of Executive Board & Executive Director
Scott T. SmithCFO
Chief Financial Officer, Executive Vice President & Member of Executive Board
Pedersen Anni Lotte Kirstine Sonderbjerg
Executive Vice President, Chief Administrative Officer & Member of the Executive Board
Michael Wolff Jensen L.L.M.
Executive Vice President, Chief Legal Officer & Member of the Executive Board
Kennett Sprogoe Ph.D.
Executive Vice President and Head of Research & Product Development
Stina Singel M.D., Ph.D.
Executive Vice President & Head of Clinical Development for Oncology
Sherrie Glass
Chief Business Officer
Total 8 executives

ASND Frequently asked questions

What is Ascendis Pharma A/S (ASND) Stock Price?

Current stock price of Ascendis Pharma A/S (ASND) stock is $260.25. The stock price is -1.06% lower in the session. The intraday range can be seen from this page. Volume of Ascendis Pharma A/S (ASND) stock is 559.70K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Ascendis Pharma A/S (ASND) stock price going up or down today?

The stock price of Ascendis Pharma A/S (ASND) can change with earnings, company news, and overall market sentiment. Ascendis Pharma A/S operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Ascendis Pharma A/S stock expensive at its current price?

Whether Ascendis Pharma A/S looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ASND on this page is -107.54. EPS on this page is -2.42. Compare those figures with peers and growth expectations before deciding if the current Ascendis Pharma A/S price is justified.

How has the stock price of Ascendis Pharma A/S (ASND) performed historically?

Historical performance for Ascendis Pharma A/S (ASND) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ASND reacted to past earnings and market events.

Should I buy Ascendis Pharma A/S (ASND) stock, at this price?

Buying Ascendis Pharma A/S (ASND) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.